REVIVA PHARMA HLDGS INC
RVPH
RVPH was delisted on the 13th of May, 2026.
12 hedge funds and large institutions have $12.8M invested in REVIVA PHARMA HLDGS INC in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
280% more capital invested
Capital invested by funds: $3.37M → $12.8M (+$9.41M)
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
50% more funds holding
Funds holding: 8 → 12 (+4)
1.12% more ownership
Funds ownership: 0.32% → 1.44% (+1.1%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$6.05M |
| 2 |
AC
Armistice Capital
New York
|
+$3.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.67M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$341K |
| 5 |
BlackRock
New York
|
+$92.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$210K |
| 3 |
Millennium Management
New York
|
-$203K |
| 4 |
DC
Davenport & Co
Richmond,
Virginia
|
-$25.2K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
1
Tang Capital Management
San Diego,
California
| $5.83M | +$6.05M | +60,000 | New |
|
|
AC
2
Armistice Capital
New York
| $3.47M | +$3.6M | +35,735 | New |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $2.57M | +$2.67M | +26,473 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $329K | +$341K | +3,386 | New |
|
|
ECM
5
EMC Capital Management
Houston,
Texas
| $257K | – | – | – |
|
|
6
BlackRock
New York
| $89K | +$92.3K | +916 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $61K | +$52.4K | +520 | +500% |
|
8
Renaissance Technologies
New York
| $55K | +$56.7K | +563 | New |
|
9
Northern Trust
Chicago,
Illinois
| $51K | +$53.3K | +529 | New |
|
|
DC
10
Davenport & Co
Richmond,
Virginia
| $49K | -$25.2K | -250 | -33% |
|
11
UBS Group
Zurich,
Switzerland
| $10K | +$10.3K | +102 | New |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| – | -$2.4M | -20,922 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$210K | -1,833 | Closed |
|
|
14
Millennium Management
New York
| – | -$203K | -1,766 | Closed |
|
|
WAM
15
Wolverine Asset Management
Chicago,
Illinois
| – | -$17K | -154 | Closed |
|
RVPH Hedge Fund Activity: Q2 2021 in Review
12 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q2 2021, worth a combined $12.8M — up 280% from $3.37M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RVPH positions and 4 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $6.05M. The largest seller was Sabby Management, exiting entirely with an estimated $2.4M sold.
- 12 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q2 2021, up from 8 in Q1 2021.
- Funds reported $12.8M of REVIVA PHARMA HLDGS INC stock for Q2 2021, up 280% quarter-over-quarter.
- 8 funds opened new REVIVA PHARMA HLDGS INC positions in Q2 2021 and 4 closed out, a net change of +4 holders.
- The largest REVIVA PHARMA HLDGS INC buyer in Q2 2021 was Tang Capital Management, an estimated $6.05M added.
- The largest REVIVA PHARMA HLDGS INC seller in Q2 2021 was Sabby Management, an estimated $2.4M sold.
Based on aggregated 13F filings for Q2 2021.